Biological Dose Escalation—Do We Have a New Window of Opportunity in High-Grade Glioma?—A Feasibility Study
Main Authors: | Bindhu Joseph, Rasla Parween, Lokesh Vishwanath, Shwetha Bondel, Mohammed Abdul Fatha |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
|
Series: | South Asian Journal of Cancer |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1776341 |
Similar Items
-
To Optimize Radiotherapeutic Plans for Superior Tumor Coverage Predicts Malignant Glioma Prognosis and Normal Tissue Complication Probability
by: Chun-Yuan Kuo, et al.
Published: (2022-04-01) -
Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
by: Qin Zhang, et al.
Published: (2022-01-01) -
Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
by: Sun Mao, et al.
Published: (2023-02-01) -
Dosimetric evaluation of IMRT Step and Shoot/ Sliding and Window (SS / SW) and VMAT Treatment Plans for Nasopharyngeal Cancer
by: Rachid Errifai, et al.
Published: (2022-01-01) -
11-year workload and barrier analysis for a high-energy linear accelerator
by: Isabela Rodrigues Rigo, et al.
Published: (2021-06-01)